Biochemistry, Genetics and Molecular Biology
| ISSN | 20593635, 20959907 |
|---|---|
| Country | United Kingdom |
| Publisher | Springer Nature |
| Subject Areas | Biochemistry, Genetics and Molecular Biology |
| Publication Type | Journals |
| Active Years | 2016-2021 |
| Website | Visit journal |
| JIF 2022–2023 | 40.800 |
| 2020-2021 SCR Rank | 160 |
Signal Transduction and Targeted Therapy is an international peerreviewed openaccess journal that publishes original research articles and review articles related to all aspects of signal transduction in physiological and pathological processes as well as signal transductiontargeted therapeutics in the form of biological agents and small molecular drugs used to treat human diseases such as cancer autoimmune disorders and others. This journal focuses on cuttingedge advances both experimentally and clinically.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 18.937 | 18.792 | 19.083 |
| 2021 | 17.389 | 17.870 | 19.468 |
| 2020 | 12.734 | 16.168 | 16.237 |
| 2019 | 13.368 | 12.899 | 12.899 |
| 2018 | 6.000 | 6.000 | 6.000 |
| 2017 | 5.429 | 5.429 | 5.429 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 8.737 |
| 2022 | 6.630 |
| 2021 | 5.157 |
| 2020 | 4.284 |
| 2019 | 3.755 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 117.000 |
| 2022 | 83.000 |
| 2021 | 53.000 |
https://mts-sigtrans.nature.com/cgi-bin/main.plex